Managing Anxiety and Depression in Parkinson’s Disease

A combination of medication and other therapies can help ease non-motor symptoms affecting those with Parkinson’s disease.

1:00 PM

Author | Andrew J. Ridder, M.D.

Silhouette showing anxiety & depression in Parkinson’s disease

Most people think of Parkinson's disease as marked only by tremors, muscular rigidity and slow, imprecise movements, but Parkinson's is more than a movement disorder.

Most people with Parkinson's also have quite a few non-motor symptoms, such as anxiety, depression and psychosis. Many of these symptoms may have started before the Parkinson's disease became obvious.

The effects are widespread. Several years ago, a large clinical study of more than 1,000 people with Parkinson's disease of various durations demonstrated that only 1.4 percent of the participants did not report any non-motor symptoms.

In other words, 98.6 percent of the study participants had some form of NMS. Psychiatric symptoms accounted for 60 percent, while visual hallucinations that could have signified psychosis were present in about 35 percent of patients.

That's why taking action is important. If you or a loved one has had a new diagnosis of Parkinson's disease, we recommend an immediate evaluation for depression, mood and cognitive problems. Frequent monitoring should also be done throughout the course of the disease.

Here are some of the common symptoms and treatment methods for Parkinson's patients with depression and dementia:

Identifying and treating depression

Between 17 to 50 percent of patients with Parkinson's have depression. Depression and Parkinson's have so many similar-looking symptoms that it is hard to tell the difference between them.

It's important to note, however, that depression is not a reaction to the disability. Rather, it seems to be related to the degeneration of specific neurons in Parkinson's disease itself.

Typical symptoms include:

  • Sadness

  • Pessimism

  • Decreased interest in activities

  • Slowing of movements

  • Fatigue

  • Mild to moderate depression

Major depression is accompanied with guilt and self-blame, which you don't often see in Parkinson's disease depression.

To treat depression in these cases, we would use the same treatments used to treat depression in the general population.

  • Selective serotonin reuptake inhibitors (SSRIs) such as paroxetine or sertraline

  • Serotonin/norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine

  • Tricyclic antidepressants or MAO-B inhibitors are rarely used

  • Cognitive behavioral therapy: A type of psychotherapy in which the patient is given the tools to change negative patterns of thought about how they're reacting to things, coping with family members and their abilities. It is often combined with medications.

  • Vagus nerve stimulation, also known as vagal nerve stimulation: A medical treatment that involves delivering electrical impulses to the vagus nerve. It is used as an additional therapy for treatment-resistant depression and certain types of uncontrollable epilepsy. If you have deep brain stimulation leads in, this is not an option.

  • Electroconvulsive therapy, also known as electroshock therapy: A procedure done under general anesthesia in which small electric currents are passed through the brain to intentionally trigger a brief seizure. This seems to cause changes in brain chemistry that can quickly reverse symptoms of certain mental illness. It is highly effective and well tolerated in refractory depression.

Anxiety: Symptoms and treatment

About 5 to 40 percent of people with Parkinson's disease also have a clinical diagnosis of anxiety — feelings of worry, nervousness or unease that may be accompanied by compulsive behavior or panic attacks. Some of these symptoms can be worse or occur only when Sinemet is wearing off ("off times").

To treat anxiety in Parkinson's patients, we would use one or a combination of the following:

  • Cognitive behavioral therapy

  • Psychotherapy

  • Relaxation techniques

  • Adjust the carbidopa-levodopa (Sinemet) regiment to treat any anxiety that occurs during medication "off" times

  • Medications used for depression as described above usually work well for anxiety

  • Anxiolytics like lorazepam (Ativan) or diazepam (Valium) are rarely used due to effects on thinking and alertness

A need for caution

Doctors have to be careful which medications they prescribe. Some antipsychotic medications, for example, risk making Parkinson's motor symptoms worse — or, in combination with Parkinson's medications, can worsen any psychosis.

Watch Dr. Ridder's talk from the University of Michigan's 2016 Parkinson's & You Symposium. Dr. Ridder explains the non-motor (non-movement) cognitive and psychiatric problems seen in people with Parkinson's disease, focusing on frequency, symptoms and treatment options.

More Articles About: Health Management Parkinson's Disease anxiety Depression Neurological (Brain) Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories family smiling togehter
Health Lab
Ketogenic diet helps 4-year-old live seizure free
Last year, a young girl experienced up to 40 seizures a week. Today, after nearly a year of working with the ketogenic diet team at University of Michigan Health C.S. Mott Children’s Hospital – overseen by a pediatric neurologist and dietitian – she’s celebrating six months of seizure freedom.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
A new pill for postpartum depression?
The fast-acting pill, paired with psychosocial treatment, offers a comprehensive treatment plan, but price concerns remain. Visit Health Lab to read the full story.
Health Lab
Managing scleroderma symptoms through a team approach
Research published in the Arthritis Care and Research Journal from Michigan Medicine found that scleroderma patients made significant strides when working with trained peer health coaches in adhering to wellness routines, leading to resilience and improvements in fatigue, pain and depressive symptoms.
vial of blood in container lab blue yellow grainy graphic
Health Lab
Drawing a tube of blood could assess ALS risk from environmental toxin exposure
Investigators have developed an environmental risk score that assesses a person’s risk for developing ALS, as well as for survival after diagnosis, using a blood sample.
Michigan Medicine neuroscientist Huda Akil, Ph.D., accepts National Medal of Science from President Joe Biden.
News Release
U-M neuroscientist Huda Akil, Ph.D., wins National Medal of Science
Distinguished U-M neuroscientist Huda Akil, Ph.D., has received the nation’s highest scientific honor – the National Medal of Science -- for her contributions to science and their impact on humankind’s understanding of depression, anxiety, addiction and more.
cells floating pink purple green
Health Lab
Scientists develop new model for understanding sudden death in epilepsy
Researchers at the University of Michigan have developed a model for studying one type of familial epilepsy, opening the door to understanding—and eventually targeting—the mechanisms that lead to the disorder and its associated fatalities.